Efficacy and Safety Evaluation of Buyang Huanwu Decoction Combined with Wuling Powder in the Treatment of Deep Vein Thrombosis after Fracture

Abstract

Objective: To explore the effect and safety of Buyang Huanwu Decoction combined with Wuling Powder in the treatment of deep vein thrombosis after fracture. Methods: A total of 76 patients with deep vein thrombosis after fracture were selected as the research object, and the enrollment period was from June 2018 to December 2019. Patients in the reference group were randomly divided into a reference group and a study group. Patients in the reference group were treated with conventional western medicine, and the study group was treated with Buyang Huanwu Decoction combined with Wuling Powder on the basis of conventional Western medicine treatment. The curative effect, adverse reactions and inflammatory factor levels after treatment of patients with deep vein thrombosis after fracture were compared between the two groups. Results: The total effective rate of treatment for patients with deep vein thrombosis after fracture in the study group was 100.00% higher than that of the reference group 86.84%, and the incidence of adverse reactions was 2.63% lower than that of the reference group 18.42%. Inflammatory factors (IL-6, TNF-α, CRP) The level was lower than the reference group, the difference was statistically significant (P<0.05). Conclusion: The development of Buyang Huanwu Decoction combined with Wuling Powder for the treatment of deep vein thrombosis after fracture can effectively improve the clinical treatment effect and medication safety, and improve the level of inflammatory factors.